-+ 0.00%
-+ 0.00%
-+ 0.00%

REVOLUTION MEDICINES PRESENTS INITIAL DATA FROM ZOLDONRASIB (RMC-9805) STUDY IN PATIENTS WITH KRAS G12D MUTANT NON-SMALL CELL LUNG CANCER AT THE 2025 AACR ANNUAL MEETING

Reuters·04/27/2025 16:05:00

Please log in to view news